Inherited retinal diseases are now the most common cause of blindness in working age adults in England and Wales, and the second commonest in childhood. Currently, there is no cure or specific treatment.
We looked for new and emerging technologies that aim to slow or stop disease progression and/or reverse sight loss. We asked clinical experts and two patient focus groups (facilitated by the charity Fight for Sight) to comment on the potential for future impact of the technologies we identified on patients and the health service. The patient focus groups provided valuable insights into the technologies from a potential user’s perspective.